-
US woman who survived botched execution is awake and speaking
-
Russia's plague scare: What we know
-
From 1800s to modern pharma: a Nobel-winning chemistry quest
-
French luxury giant to fund redevelopment of two Paris streets: city hall
-
Southampton boss Eckert given suspended ban over 'Spygate'
-
Trump wants to turn Florida golf course into presidential retreat
-
Russia warns of 'false' information as second plague case reported
-
Mayor of Turkish opposition stronghold defects to Erdogan party
-
IEA ready to release more oil reserves if necessary
-
Children among heavy casualties in Ukraine after Russian strikes
-
HSBC 'consults' over UK unit job cuts amid AI adoption
-
Court orders German ex-spy chief kept in jail after spying, treason arrest
-
UK court quashes five ex-traders' Libor rate rigging convictions
-
Guinea caps bottled water prices after sachets banned
-
XM Receives “Global Customer Experience Leader Award 2026” at the TrustFinance Performance Awards
-
Spared, married, hanged: the last weeks of Iranian protester Alireza Sepahi
-
Stocks slide as oil climbs on Mideast flareup
-
Nobel physics winner's pride at pioneering AI role
-
Heavy casualties in Ukraine after Russian strikes
-
IMF preparing El Nino assistance, concerned about AI bubble burst: chief to AFP
-
French wine harvest set to hit historic low
-
West must embrace 'national power' or face decline: Rubio
-
Kyiv 'cannot agree' to EU membership limiting food exports: minister
-
Shell refining margins reach record highs as wars hit supply
-
Arteta targets more Arsenal glory after signing new deal until 2030
-
Former Spain, Barca winger Pedro retires from football
-
Russell hit with Singapore grid penalty for taking new power unit
-
Arteta signs new Arsenal deal until 2030
-
Spotify expands audiobooks to more than 180 markets
-
Stocks decline as oil climbs on Mideast flareup
-
French-Japanese duo wins chemistry Nobel for solving molecular 'mystery'
-
Gauff says online abuse was 'draining' after China Open exit
-
England's Nations League surge helps heal World Cup wounds
-
As sector struggles, Porsche puts luxury ahead of volume
-
Mayor of opposition stronghold Izmir defects to Erdogan party
-
'It's personal': Fiji minister pushes better climate finance at pre-COP
-
Mertens beats Gauff to set up Swiatek clash at China Open
-
Russia glosses over dark Soviet past in reinvented museum
-
Benin full of pride at role in Messi's last dance
-
UK tax body opened probe into Man City in 2018: FT
-
France suspends stun grenade use at student protests ahead of PM speech
-
Yemen's Houthis claim new attacks on Saudi airports as conflict deepens
-
Indonesian court hears 'negligence' complaint against state over fires, haze
-
Germany factory production at highest level for 18 months
-
Rubio in Greece to urge against Western civilisation 'decline'
-
Thailand floods death toll rises to 60 since mid-September
-
Micron workers at Taiwan plant vote in favour of strike
-
US pushes Russia for information on plague reports
-
In 'The Social Reckoning,' Jeremy Allen White takes on Facebook's 'frightening' ambition
-
Myanmar leader lands in Malaysia for migrant return talks
China says shared Covid information 'without holding anything back'
Beijing insisted on Tuesday that it had shared information on Covid-19 "without holding anything back", after the World Health Organization implored China to offer more data and access to understand the disease's origins.
Covid-19, which first emerged in the central Chinese city of Wuhan in December 2020, went on to kill millions of people, shred economies and overwhelm health systems.
The WHO published a statement on Monday saying it was a "moral and scientific imperative" for China to share more information.
In response, China defended its transparency, saying it had made the "largest contribution to global origin tracing research".
"Five years ago... China immediately shared epidemic information and viral gene sequence with the WHO and the international community," foreign ministry spokeswoman Mao Ning said.
"Without holding anything back, we shared our prevention, control and treatment experience," she told reporters at a regular press briefing.
But over the course of the pandemic, the WHO repeatedly criticised Chinese authorities for their lack of transparency and cooperation.
A team of specialists led by the WHO and accompanied by Chinese colleagues conducted an investigation into the pandemic's origins in early 2021.
In a joint report, they favoured the hypothesis that the virus had been transmitted by an intermediary animal from a bat to a human, possibly at a market.
A team has not been able to return to China since, and WHO officials have repeatedly asked for additional data.
Mao said Tuesday that "more and more clues" pointed "to Covid-19's origins having a global scope".
China was "willing to continue working with various parties to promote global scientific origin tracing, and to make active efforts to prevent potential infectious diseases in the future", she said.
- Pandemic preparedness -
This month, WHO Director-General Tedros Adhanom Ghebreyesus said "the world would still face some of the same weaknesses and vulnerabilities that gave Covid-19 a foothold five years ago", if a new pandemic emerged today.
"But the world has also learnt many of the painful lessons the pandemic taught us, and has taken significant steps to strengthen its defences against future epidemics and pandemics," he said.
In December 2021, spooked by the devastation caused by Covid, countries decided to start drafting an accord on pandemic prevention, preparedness and response.
The WHO's 194 member states negotiating the treaty have agreed on most of what it should include, but are stuck on the practicalities.
A key fault line lies between Western nations with major pharmaceutical industry sectors and poorer countries wary of being sidelined when the next pandemic strikes.
While the outstanding issues are few, they include the heart of the agreement: the obligation to quickly share emerging pathogens, and then the pandemic-fighting benefits derived from them such as vaccines.
The deadline for the negotiations is May 2025.
H.Nasr--SF-PST